AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Algorae Pharmaceuticals Ltd

0.004

+0.002100.00%

Volume:37.53M

Turnover:130.03K

Market Cap:6.75M

PE:- -

High:0.004

Open:0.003

Low:0.003

Close:0.002

52wk High:0.004

52wk Low:0.001

Shares:1.69B

Float Shares:1.04B

Volume Ratio:60.74

T/O Rate:3.59%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Algorae Pharmaceuticals Ltd

Exchange:

ASX

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.lctglobal.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Algorae Pharmaceuticals Limited, a biotechnology company, focuses on developing solutions for Parkinson's disease in Australia. It is developing NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient treatment for dementia, including Alzheimer's disease. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. The company was founded in 1987 and is based in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/1AIO.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"1AIO.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AIO.AU\",,,,,undefined,":{"symbol":"1AIO.AU","market":"AU","secType":"STK","nameCN":"Algorae Pharmaceuticals Ltd","latestPrice":0.004,"timestamp":1764911520000,"preClose":0.002,"halted":0,"volume":37529519,"delay":0,"nameEN":"Algorae Pharmaceuticals Ltd","floatShares":1044999999,"shares":1688000000,"eps":0,"marketStatus":"Not Yet Opened","change":0.002,"latestTime":"12-05 16:12:00 AEDT","open":0.003,"high":0.004,"low":0.003,"amount":130029,"amplitude":0.5,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1765148400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.002,"openAndCloseTimeList":[[1764889200000,1764910800000]],"volumeRatio":60.73720504542889,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AIO.AU\",,,,,undefined,":{"symbol":"1AIO.AU","floatShares":1044999999,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":60.73720504542889,"shares":1688000000,"dividePrice":0,"high":0.004,"amplitude":0.5,"preClose":0.002,"low":0.003,"week52Low":0.001,"pbRate":"--","week52High":0.004,"institutionHeld":0,"latestPrice":0.004,"eps":0,"divideRate":0,"volume":37529519,"delay":0,"ttmEps":0,"open":0.003,"prevYearClose":0.002,"fiveDayClose":0.003,"twentyDayClose":0.002,"sixtyDayClose":0.002},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/1AIO.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"1AIO.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.lctglobal.com","stockEarnings":[{"period":"1week","weight":0.3333},{"period":"1month","weight":1},{"period":"3month","weight":1},{"period":"6month","weight":3},{"period":"1year","weight":1},{"period":"ytd","weight":1}],"compareEarnings":[{"period":"1week","weight":-0.0027},{"period":"1month","weight":0.0109},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0736},{"period":"1year","weight":0.2212},{"period":"ytd","weight":0.2311}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Algorae Pharmaceuticals Limited, a biotechnology company, focuses on developing solutions for Parkinson's disease in Australia. It is developing NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient treatment for dementia, including Alzheimer's disease. The company was formerly known as Living Cell Technologies Limited and changed its name to Algorae Pharmaceuticals Limited in September 2023. The company was founded in 1987 and is based in Melbourne, Australia.","exchange":"ASX","name":"Algorae Pharmaceuticals Ltd","nameEN":"Algorae Pharmaceuticals Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"1AIO.AU\",market:\"AU\",,,undefined,":null}}